Detalles de la búsqueda
1.
KIR-favorable TCR-αß/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial.
Blood;
140(24): 2556-2572, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776909
2.
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.
Br J Haematol;
200(1): 54-63, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36120837
3.
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
Blood;
137(10): 1416-1423, 2021 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33120429
4.
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Br J Haematol;
197(2): 212-222, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106754
5.
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Br J Haematol;
195(5): 757-763, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581433
6.
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant;
26(6): 1099-1105, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32165327
7.
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Cancer;
126(10): 2279-2287, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32049359
8.
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
Br J Haematol;
190(4): 573-582, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314807
9.
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Biol Blood Marrow Transplant;
25(9): 1859-1868, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31132455
10.
Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.
Br J Haematol;
2024 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797526
11.
Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
24(5): 983-988, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410340
12.
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant;
24(6): 1163-1171, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29242111
13.
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.
Blood;
127(7): 938-47, 2016 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26670632
14.
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.
Biol Blood Marrow Transplant;
23(8): 1295-1302, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28412518
15.
Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit.
Haematologica;
107(5): 1214-1217, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112554
16.
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.
Hematol Oncol;
35(4): 528-535, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28066928
17.
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
Br J Haematol;
174(2): 235-48, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26989808
18.
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
Leukemia;
2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750138
19.
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.
Br J Haematol;
182(6): 916-920, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28771676
20.
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning.
Bone Marrow Transplant;
58(11): 1203-1208, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563283